ArticleThe American journal of case reports2026
Electrocardiographic and Arrhythmic Manifestations of End-Stage Atrial Myopathy in Patients With Longstanding Persistent or Permanent Atrial Fibrillation: A 3-Patient Case Series.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Advanced atrial remodeling, often associated with atrial fibrosis, may be accompanied by severe atrial electrical dysfunction and a range of electrocardiographic and arrhythmic manifestations. Data on the clinical features of this process are limited. CASE REPORT We report 3 patients with end-stage atrial myopathy and longstanding persistent or permanent atrial fibrillation (AF). One patient with extensive biatrial scar developed recurrent low-amplitude atrial tachycardias after AF ablation. Two patients demonstrated progression from AF to atrial standstill with junctional rhythms. In both patients, serial ECGs showed loss of fibrillatory activity, and device interrogation demonstrated absent atrial sensing and capture. One patient underwent pacemaker implantation without atrial lead placement, due to the absence of atrial sensing or capture on electrophysiology mapping. Important coexisting substrates for atrial remodeling included hypertrophic cardiomyopathy, mitral valve disease, and prior cardiac surgeries. CONCLUSIONS Patients with longstanding persistent or permanent AF may demonstrate distinct findings suggestive of advanced atrial myopathy, including loss of fibrillatory waves on ECG, low-amplitude atrial tachycardias, atrial standstill, junctional rhythms, absent atrial sensing or capture on device interrogation, and extensive atrial scarring on electrophysiology mapping. Recognition of these clinical manifestations may provide insight into advanced atrial remodeling and potentially inform AF ablation and atrial pacing strategies. Further studies are needed to better define the mechanisms, prevalence, and clinical significance of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.